Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Abnormal hypermethylation and clinicopathological significance of Axin gene in lung cancer.

Yang LH, Xu HT, Li QC, Jiang GY, Zhang XP, Zhao HY, Xu K, Wang EH.

Tumour Biol. 2013 Apr;34(2):749-57. doi: 10.1007/s13277-012-0604-z. Epub 2012 Nov 29.

PMID:
23192643
2.

Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.

Xie XM, Zhang ZY, Yang LH, Yang DL, Tang N, Zhao HY, Xu HT, Li QC, Wang EH.

Int J Oncol. 2013 Nov;43(5):1636-42. doi: 10.3892/ijo.2013.2084. Epub 2013 Aug 29.

PMID:
24002585
3.

Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.

Xu HT, Wei Q, Liu Y, Yang LH, Dai SD, Han Y, Yu JH, Liu N, Wang EH.

Ann Surg Oncol. 2007 Nov;14(11):3251-9. Epub 2007 Sep 1.

PMID:
17768662
4.

Axin gene methylation status correlates with radiosensitivity of lung cancer cells.

Yang LH, Han Y, Li G, Xu HT, Jiang GY, Miao Y, Zhang XP, Zhao HY, Xu ZF, Stoecker M, Wang E, Xu K, Wang EH.

BMC Cancer. 2013 Aug 2;13:368. doi: 10.1186/1471-2407-13-368.

5.

[Effect of adenomatous polyposis coli(APC) promoter methylation on gene transcription in lung cancer cell lines].

Zhang LX, Pan SY, Chen D, Xie EF, Gao L, Shu YQ, Lu ZH, Cheng L, Yang D, Zhang JN.

Ai Zheng. 2007 Jun;26(6):576-80. Chinese.

PMID:
17562260
6.
7.

Hypermethylation of the GATA genes in lung cancer.

Guo M, Akiyama Y, House MG, Hooker CM, Heath E, Gabrielson E, Yang SC, Han Y, Baylin SB, Herman JG, Brock MV.

Clin Cancer Res. 2004 Dec 1;10(23):7917-24.

8.

Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.

Selinger CI, Cooper WA, Al-Sohaily S, Mladenova DN, Pangon L, Kennedy CW, McCaughan BC, Stirzaker C, Kohonen-Corish MR.

J Thorac Oncol. 2011 Jul;6(7):1179-89. doi: 10.1097/JTO.0b013e31821b4ce0.

9.

XAF1 is frequently methylated in human esophageal cancer.

Chen XY, He QY, Guo MZ.

World J Gastroenterol. 2012 Jun 14;18(22):2844-9. doi: 10.3748/wjg.v18.i22.2844.

10.

The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.

Chen JT, Cheng YW, Chou MC, Sen-Lin T, Lai WW, Ho WL, Lee H.

Clin Cancer Res. 2003 Sep 15;9(11):4200-4.

11.

Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.

Tang R, Zhong T, Dang Y, Zhang X, Li P, Chen G.

Clin Transl Oncol. 2016 Apr;18(4):360-8. doi: 10.1007/s12094-015-1377-9. Epub 2015 Aug 26.

PMID:
26307752
12.

Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.

Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Minna JD, Fujisawa T, Gazdar AF.

Ann Surg Oncol. 2007 Apr;14(4):1397-404. Epub 2006 Dec 29.

PMID:
17195088
13.

Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.

Miao Y, Wang L, Zhang X, Xu X, Jiang G, Fan C, Liu Y, Lin X, Yu J, Zhang Y, Wang E.

PLoS One. 2014 Nov 14;9(11):e112258. doi: 10.1371/journal.pone.0112258. eCollection 2014.

14.

Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma.

Ramnath N, Nadal E, Jeon CK, Sandoval J, Colacino J, Rozek LS, Christensen PJ, Esteller M, Beer DG, Kim SH.

J Thorac Oncol. 2014 Apr;9(4):473-82. doi: 10.1097/JTO.0000000000000114.

15.

Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.

Liu WB, Han F, Du XH, Jiang X, Li YH, Liu Y, Chen HQ, Ao L, Cui ZH, Cao J, Liu JY.

Int J Cancer. 2014 Mar 15;134(6):1311-22. doi: 10.1002/ijc.28472. Epub 2013 Nov 11.

16.

The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer.

Ma L, Dong S, Zhang P, Xu N, Yan H, Liu H, Li Y, Zhou Q.

Clin Lab. 2010;56(9-10):407-16.

PMID:
21086786
17.

WT1 promotes invasion of NSCLC via suppression of CDH1.

Wu C, Zhu W, Qian J, He S, Wu C, Chen Y, Shu Y.

J Thorac Oncol. 2013 Sep;8(9):1163-9. doi: 10.1097/JTO.0b013e31829f6a5f.

18.

Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.

Borges S, Döppler H, Perez EA, Andorfer CA, Sun Z, Anastasiadis PZ, Thompson E, Geiger XJ, Storz P.

Breast Cancer Res. 2013 Aug 23;15(2):R66. doi: 10.1186/bcr3460.

19.

[Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells].

Fang HL, Yu ZC, Zhu HB, Jin YT.

Zhonghua Zhong Liu Za Zhi. 2012 Sep;34(9):658-63. doi: 10.3760/cma.j.issn.0253-3766.2012.09.004. Chinese.

PMID:
23159077
20.

X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.

Han Y, Wang Y, Xu HT, Yang LH, Wei Q, Liu Y, Zhang Y, Zhao Y, Dai SD, Miao Y, Yu JH, Zhang JY, Li G, Yuan XM, Wang EH.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):518-26. doi: 10.1016/j.ijrobp.2009.05.040.

PMID:
19735876

Supplemental Content

Support Center